Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?

Kidney International

Volumn 68, Issue 4, 2005, Pages 1808-1814

  Saigal, Christopher S ^a   Joyce, Geoffrey ^b   Timilsina, Anga R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Costs; Economics; Kidney stones; Nephrolithiasis

Indexed keywords

ADULT; ARTICLE; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH STATUS; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHROLITHIASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; EMPLOYMENT; FEMALE; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; KIDNEY CALCULI; MALE; MIDDLE AGED; PREVALENCE; SICK LEAVE;

EID: 31644436904     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00599.x     Document Type: Article

References (16)

1. RICE DP, HODGSON TA, KOPSTEIN AN: The economic costs of illness: A replication and update. Health Care Financ Rev 7:61-80, 1985
2. LJUNGHALL S: Incidence of upper urinary tract stones. Mineral Electrolyte Metab 13:220-227, 1987
3. GOLDFARB DS: Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951-1952, 2003
4. STAMATELOU KK, FRANCIS ME, JONES CA, et al: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63:1817-1823, 2003
5. Coping with Kidney Stones, in, Harvard Women's Health Watch (online: http://www.health.harvard.edu/hhp/article/content.do?name=W1101c), November, 2001
6. MARDIS HK, PARKS JH, MULLER G, et al: Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. J Urol 171:85-88, 2004
7. PEARLE MS, ROEHRBORN CG, PAK CY: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679-685, 1999
8. GRASES F, COSTA-BAUZÁ A, RAMIS M, et al: Recurrence of renal lithiasis. Scand J Urol Nephrol 37:482-486, 2003
9. SELTZER MA, LOW RK, MCDONALD M, et al: Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 156:907-909, 1996
10. SEGURA JW, PREMINGER GM, ASSIMOS DG, et al: Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 158:1915-1921, 1997
11. KIM SC, KUO RL, LINGEMAN JE: Percutaneous nephrolithotomy: an update. Curr Opin Urol 13:235-241, 2003
12. SHUSTER J, SCHEAFFER RL: Economic impact of kidney stones in white male adults. Urology 24:327-331, 1984
13. CLARK JY, THOMPSON IM, OPTENBERG SA: Economic impact of urolithiasis in the United States. J Urol 154:2020-2024, 1995
14. LEONG SA, BARGHOUT V, BIRNBAUM HG, et al: The economic consequences of irritable bowel syndrome: A US employer perspective. Arch Intern Med 163:929-935, 2003
15. RAMSEY S, SUMMERS KH, LEONG SA, et al: Productivity and medical costs of diabetes in a large employer population. Diabetes Care 25:23-29, 2002
16. BIRNBAUM HG, BERGER WE, GREENBERG PE, et al: Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 109:264-270, 2002